Linvoseltamab (LINVO) plus carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the LINKER-MM2 trial.
Por:
Manier, S, Ocio, EM, Martinez-Chamorro, C, Delimpasi, S, Oriol, A, Dimopoulos, MA, Leleu, XP, Rubinstein, S, Joseph, NS, Mesa, MG, Chakraborty, R, de Larrea, CF, Breazna, A, Drew, J, Boyapati, A, Hazra, A, Kroog, GS, Sarkaria, SM and Rodríguez-Otero, P
Publicada:
1 jun 2025
Resumen:
Filiaciones:
Manier, S:
Lille Univ Hosp, Hematol Dept, Lille, France
Ocio, EM:
Hosp Univ Marques Valdecilla Univ Hosp IDIVAL Univ, Serv Hematol & Hemoterapia, Santander, Spain
Martinez-Chamorro, C:
Hosp Univ Quironsalud Madrid, Hematol Dept, Madrid, Spain
Univ Europea Madrid, Madrid, Spain
Delimpasi, S:
Gen Hosp Evangelismos, Dept Hematol & Bone Marrow Transplantat Unit, Athens, Greece
:
Inst Josep Carreras Hosp Germans Trias I Pujol, Dept Hematol, Inst Catala Oncol, Badalona, Spain
Dimopoulos, MA:
Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece
Leleu, XP:
University, CHU, Hematol, U1313,CIC 1082, Poitiers, France
Rubinstein, S:
Univ N Carolina, Dept Hematol Oncol, Durham, NC USA
Joseph, NS:
Emory Univ, Winship Canc Inst, Atlanta, GA USA
Mesa, MG:
Vall dHebron Hosp, Hematol Dept, Barcelona, Spain
Chakraborty, R:
Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
de Larrea, CF:
Univ Barcelona, Hosp Clin Barcelona, Hematol Dept, Amyloid & Myeloma Unit, Barcelona, Spain
Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain
Breazna, A:
Regeneron Pharmaceut Inc, Tarrytown, NY USA
Rodríguez-Otero, P:
Clin Univ Navarra, Dept Hematol, Pamplona, Spain
|